Wakatsuki A, Ikenoue N, Sagara Y
Department of Obstetrics and Gynecology, Kochi Medical School, Japan.
Obstet Gynecol. 1998 Feb;91(2):234-40. doi: 10.1016/s0029-7844(97)00651-0.
To investigate the mechanisms of an estrogen-induced decrease in the size of low-density lipoprotein (LDL) particles in postmenopausal women.
Twenty postmenopausal women were treated with conjugated equine estrogen, 0.625 mg daily, for 3 months. Plasma levels of total cholesterol, triglyceride, high-density lipoprotein (HDL) cholesterol, and apolipoproteins AI, AII, and B were measured before and after therapy. We analyzed total, free, and esterified cholesterol, triglyceride, phospholipid, and apolipoprotein B levels in the LDL. Cholesterol, triglyceride, and phospholipid concentrations were measured by enzymatic methods. Apolipoprotein AI, AII, and B levels were determined by immunoturbidimetric assay. The diameter of LDL particles was determined by gradient gel electrophoresis.
Estrogen reduced significantly the plasma levels of total cholesterol and apolipoprotein B and increased significantly the plasma levels of triglyceride, HDL cholesterol, and apolipoproteins AI and AII. The ratio of cholesteryl ester to apolipoprotein B was significantly reduced, whereas the ratio of triglyceride to apolipoprotein B was significantly increased after such treatment. The plasma level of triglyceride showed a positive correlation with the ratio of LDL-triglyceride/apolipoprotein B (r = .40, P < .01), and a negative correlation with the ratio of LDL-cholesteryl ester/apolipoprotein B (r = -.55, P < .001). Estrogen treatment reduced significantly the diameter of LDL particles (25.79+/-1.13 nm versus 24.94+/-1.02 nm, P < .001). The diameter of the LDL particle was correlated negatively with the plasma level of triglyceride (r = -.84, P < .001) and the ratio of LDL-triglyceride/apolipoprotein B (r = -.58, P < .001), and positively with the ratio of LDL-cholesteryl ester/apolipoprotein B (r = .57, P < .001).
The results of this study indicate that an increase in the triglyceride plasma level induced by estrogen therapy appeared to produce small triglyceride-rich and cholesteryl ester-poor LDL particles that were of small size.
研究雌激素导致绝经后女性低密度脂蛋白(LDL)颗粒大小减小的机制。
20名绝经后女性每日服用0.625mg结合马雌激素,持续3个月。在治疗前后测量血浆总胆固醇、甘油三酯、高密度脂蛋白(HDL)胆固醇以及载脂蛋白AI、AII和B的水平。我们分析了LDL中总胆固醇、游离胆固醇和酯化胆固醇、甘油三酯、磷脂以及载脂蛋白B的水平。胆固醇、甘油三酯和磷脂浓度通过酶法测量。载脂蛋白AI、AII和B水平通过免疫比浊法测定。LDL颗粒直径通过梯度凝胶电泳测定。
雌激素显著降低了血浆总胆固醇和载脂蛋白B水平,并显著提高了血浆甘油三酯、HDL胆固醇以及载脂蛋白AI和AII水平。治疗后,胆固醇酯与载脂蛋白B的比值显著降低,而甘油三酯与载脂蛋白B的比值显著升高。血浆甘油三酯水平与LDL-甘油三酯/载脂蛋白B的比值呈正相关(r = 0.40,P < 0.01),与LDL-胆固醇酯/载脂蛋白B的比值呈负相关(r = -0.55,P < 0.001)。雌激素治疗显著减小了LDL颗粒的直径(25.79±1.13nm对24.94±1.02nm,P < 0.001)。LDL颗粒直径与血浆甘油三酯水平呈负相关(r = -0.84,P < 0.001)以及与LDL-甘油三酯/载脂蛋白B的比值呈负相关(r = -0.58,P < 0.001),与LDL-胆固醇酯/载脂蛋白B的比值呈正相关(r = 0.57,P < 0.001)。
本研究结果表明,雌激素治疗诱导的血浆甘油三酯水平升高似乎产生了富含甘油三酯且胆固醇酯含量低的小尺寸LDL颗粒。